Page last updated: 2024-11-02

pentobarbital and Jejunal Diseases

pentobarbital has been researched along with Jejunal Diseases in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Jejunal Diseases: Pathological development in the JEJUNUM region of the SMALL INTESTINE.

Research Excerpts

ExcerptRelevanceReference
" Thus, because oxygen consumption by the brain represents approximately 20 per cent of the body's oxygen needs, and pentobarbital's primary action is as a central nervous system depressant, the induction of pentobarbital coma was instituted to reduce cerebral oxygen consumption."3.75The use of barbiturate coma as salvage therapy in a postoperative Jehovah's Witness patient with life-threatening anemia. ( Badami, CD; Deitch, EA; Wang, SW, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, SW1
Badami, CD1
Deitch, EA1

Other Studies

1 other study available for pentobarbital and Jejunal Diseases

ArticleYear
The use of barbiturate coma as salvage therapy in a postoperative Jehovah's Witness patient with life-threatening anemia.
    The American surgeon, 2009, Volume: 75, Issue:12

    Topics: Anemia; Coma; Humans; Hypnotics and Sedatives; Intestinal Perforation; Jehovah's Witnesses; Jejunal

2009